Back to Journals » Drug Design, Development and Therapy » Volume 6

Drug Design, Development and Therapy


Archive: Volume 6, 2012

Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study

Smith WB, Mannaert E, Verhaeghe T, Kerstens R, Vandeplassche L, Van de Velde V

Drug Design, Development and Therapy 2012, 6:407-415

Published Date: 18 December 2012

Dabrafenib and its potential for the treatment of metastatic melanoma

Menzies AM, Long GV, Murali R

Drug Design, Development and Therapy 2012, 6:391-405

Published Date: 11 December 2012

Chronic eosinophilic pneumonia due to radiographic contrast administration: an orphan disease?

Hohenforst-Schmidt W, Riedel A, Zarogoulidis P, Franke C, Gschwendtner A, Huang H, Machairiotis N, Dramba V, Zarogoulidis K, Brachmann J

Drug Design, Development and Therapy 2012, 6:385-389

Published Date: 10 December 2012

Update on taxane development: new analogs and new formulations

Yared JA, Tkaczuk KH

Drug Design, Development and Therapy 2012, 6:371-384

Published Date: 11 December 2012

Pretreatment data is highly predictive of liver chemistry signals in clinical trials

Cai Z, Bresell A, Steinberg MH, Silberg DG, Furlong ST

Drug Design, Development and Therapy 2012, 6:359-369

Published Date: 27 November 2012

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies

Wempe MF, Lightner JW, Miller B, Iwen TJ, Rice PJ, Wakui S, Anzai N, Jutabha P, Endou H

Drug Design, Development and Therapy 2012, 6:323-339

Published Date: 8 November 2012

Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects

Tjandrawinata RR, Setiawati E, Yunaidi DA, Santoso ID, Setiawati A, Susanto LW

Drug Design, Development and Therapy 2012, 6:311-316

Published Date: 30 October 2012

Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy

Ruiz de Garibay AP, Delgado D, del Pozo-Rodríguez A, Solinís MA, Gascón AR

Drug Design, Development and Therapy 2012, 6:303-310

Published Date: 26 October 2012

Therapy effects of gold nanorods on the CNE-1 nasopharyngeal carcinoma cell line

Shao J, Tang J, Ji J, Zhou W

Drug Design, Development and Therapy 2012, 6:297-301

Published Date: 25 October 2012

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients

Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA

Drug Design, Development and Therapy 2012, 6:289-295

Published Date: 12 October 2012

Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis

Tsuboko Y, Takeda S, Mii S, Nakazato K, Tanaka K, Uchida E, Sakamoto A

Drug Design, Development and Therapy 2012, 6:273-278

Published Date: 10 October 2012

Current and novel drug therapies for idiopathic pulmonary fibrosis

Adamali HI, Maher TM

Drug Design, Development and Therapy 2012, 6:261-272

Published Date: 26 September 2012

Kinase inhibitors: a new class of antirheumatic drugs

Kyttaris VC

Drug Design, Development and Therapy 2012, 6:245-250

Published Date: 21 September 2012

Adding thiazide to a rennin-angiotensin blocker regimen to improve left ventricular relaxation in diabetes and nondiabetes patients with hypertension

Takami T, Ito H, Ishii K, Shimada K, Iwakura K, Watanabe H, Fukuda S, Yoshikawa J

Drug Design, Development and Therapy 2012, 6:225-233

Published Date: 12 September 2012

Exploring prospects of novel drugs for tuberculosis

Janssen S, Jayachandran R, Khathi L, Zinsstag J, Grobusch MP, Pieters J

Drug Design, Development and Therapy 2012, 6:217-224

Published Date: 7 September 2012

Natural material adsorbed onto a polymer to enhance immune function

Reinaque AP, França EL, Scherer EF, Côrtes MA, Souto FJ, Honorio-França AC

Drug Design, Development and Therapy 2012, 6:209-216

Published Date: 27 August 2012

The preventive role of transurethral antibiotic delivery in a rat model

Ozok HU, Ekim O, Saltas H, Arikok AT, Babacan O, Sagnak L, Topaloglu H, Ersoy H

Drug Design, Development and Therapy 2012, 6:187-194

Published Date: 17 July 2012

Erratum

Todd Levine

Drug Design, Development and Therapy 2012, 6:163-164

Published Date: 21 June 2012

Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy

Frati F, Incorvaia C, David M, Scurati S, Seta S, Padua G, Cattaneo E, Cavaliere C, Di Rienzo A, Dell'Albani I, Puccinelli P

Drug Design, Development and Therapy 2012, 6:117-123

Published Date: 18 May 2012

Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted

Lambert O, Bandilla D, Iyer R, Witchey-Lakshmanan L, Palepu N

Drug Design, Development and Therapy 2012, 6:61-70

Published Date: 28 March 2012

Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease

Nordfjeld K, Andreasen H, Thomsen LL

Drug Design, Development and Therapy 2012, 6:43-51

Published Date: 5 March 2012

Inhaled treprostinil: a therapeutic review

Channick RN, Voswinckel R, Rubin LJ

Drug Design, Development and Therapy 2012, 6:19-28

Published Date: 24 January 2012

Treatment for primary hypothyroidism: current approaches and future possibilities

Chakera AJ, Pearce SHS, Vaidya B

Drug Design, Development and Therapy 2012, 6:1-11

Published Date: 22 December 2011